Among the cancer-related factors, disease duration (OR, 0.85; 95% CI, 0.76-0.96) and GnRH treatment (OR, 1.68; 95% CI, 1.15-2.44) were associated with depression. This evidence concerns the gene GNRH1 and depressive disorder.